Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
McKesson
QuintilesIMS
Fish and Richardson
Farmers Insurance
Daiichi Sankyo
UBS
Healthtrust

Generated: May 22, 2018

DrugPatentWatch Database Preview

HYDERGINE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Hydergine, and what generic alternatives are available?

Hydergine is a drug marketed by Novartis and is included in four NDAs.

The generic ingredient in HYDERGINE is ergoloid mesylates. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ergoloid mesylates profile page.
Summary for HYDERGINE
US Patents:0
Applicants:1
NDAs:4
Bulk Api Vendors: 9
Formulation / Manufacturing:see details
DailyMed Link:HYDERGINE at DailyMed
Drug patent expirations by year for HYDERGINE
Medical Subject Heading (MeSH) Categories for HYDERGINE

US Patents and Regulatory Information for HYDERGINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis HYDERGINE ergoloid mesylates SOLUTION;ORAL 018418-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis HYDERGINE ergoloid mesylates TABLET;SUBLINGUAL 009087-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis HYDERGINE ergoloid mesylates TABLET;ORAL 017993-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis HYDERGINE ergoloid mesylates TABLET;ORAL 017993-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
AstraZeneca
Dow
Medtronic
Deloitte
Chinese Patent Office
Fish and Richardson
McKesson
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.